메뉴 건너뛰기




Volumn 22, Issue 21, 2014, Pages 5790-5803

AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization

Author keywords

Allosteric; Antagonist; mGluR5; Non competitive

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; BENZODIAZEPINE CHLORDIAZEPOXIDE; BENZODIAZEPINE DERIVATIVE; MAVOGLURANT; METABOTROPIC RECEPTOR 5; UNCLASSIFIED DRUG; 6-METHYL-2-(PHENYLETHYNYL)PYRIDINE; INDOLE DERIVATIVE; LEVODOPA; PROTEIN BINDING; PYRIDINE DERIVATIVE;

EID: 84908433180     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2014.09.033     Document Type: Article
Times cited : (47)

References (36)
  • 16
    • 84908414324 scopus 로고    scopus 로고
    • ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients with Parkinson's Disease
    • Clinicaltrials.gov: A service of the US National Institute of Health, (accessed on June 2nd, 2014)
    • ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients with Parkinson's Disease, Addex Pharmaceuticals, Clinicaltrials.gov: A service of the US National Institute of Health, http://clinicaltrials.gov/ct2/results?term=adx48621 (accessed on June 2nd, 2014).
    • Addex Pharmaceuticals
  • 17
    • 84908414323 scopus 로고    scopus 로고
    • RG7090, Roche, Pipeline update April 15th, 2014; (accessed on June 2nd, 2014)
    • RG7090, Roche, Pipeline update April 15th, 2014; http://www.roche.com/research-and-development/pipeline/roche-pharma-pipeline.htm (accessed on June 2nd, 2014).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.